Epidemiology

Epidemiology

Accurate and holistic analysis on the incidence, distribution, and control of diseases and factors relating to health.
Get In Touch
Epidemiology Research

Find the right number, understand inherent biases, and identify the strongest sources of information

The challenge isn’t finding the number – it’s finding the right number, understanding the inherent biases, and identifying the strongest sources of information to support your decisions. We help you evaluate opportunities and strengthen your pipeline by providing comprehensive and reliable epidemiology data. This way you can prioritize drug discovery.

What do you get with Epidemiology?

Explicit details about flows and assumptions

We document sources, so you can view and defend how we estimated the target population and why it’s the best measure.

Comprehensive and robust data sources
 

We have efficient and flexible access to a broad range of data, using the right sources to answer your question.

Broad commercial applications

Our experts work seamlessly across disciplines to address a broad range of commercial challenges.

Our strengths

We have experience in thousands of disease states, and a long history of custom epidemiology studies and syndicated decision-support tools. We work collaboratively across functions to address many commercial challenges. 

Sources and data

We use a number of sources to support our epidemiology engagements, including our proprietary data sets, Epi Database®, CancerMpact®, National Health and Wellness Survey (NHWS), Cerner Real-World Data™, and Claritis™, as well as peer-reviewed medical literature, government databases, national registries, self-reported patient surveys, and medical chart audits.

Therapeutic specialties

We pride ourselves on the depth of our therapeutic knowledge, including oncology and rare diseases, on a global, national, regional, and local level. We have published more than 1,500 studies in scientific and peer-reviewed journals.

Client Results

Quantify

 Clarity on market potential via patient flow models

Expand

Map out additional indications for in-line products

Learn

Identify unmet needs in previously untapped markets

Fine-tune

Accurately assess licensing opportunities